Buy now

About us


NOVOS LEVERAGES SCIENCE AND DATA TO CREATE THE BEST NUTRACEUTICALS TO EXTEND HUMAN LIFESPAN


Despite major scientific progress, there are hardly any effective, science-based anti-aging nutraceuticals.

Most longevity supplements are based on outdated ideas of aging, such as the idea that antioxidants slow down aging.

Others contain ingredients that are healthy, but unfortunately don’t extend lifespan.

Some supplements contain one or two ingredients that might extend lifespan, such as nicotinamide riboside (NR), but the jury is still out.

A much better longevity supplement would contain many ingredients that simultaneously work on multiple causes of aging, resulting in synergies that are greater than the sum of their parts.

We at NOVOS believe much more can be done to slow down aging through science, so we create the first supplements in the world that are:

  • Based on the best available science
  • Created with the world’s top experts in the aging field 
  • Use scientifically validated ingredients that extend lifespan in various organisms
  • Focused on nine or more aging mechanisms to leverage synergistic effects 
  • Include ingredients shown to have beneficial effects on aging in humans

The result is NOVOS, the best longevity supplements available.


OUR PASSION IS TO FIND SOLUTIONS TO LIVE LONGER, HEALTHIER LIVES


NOVOS’ Scientific Advisory Board & Consultants – The Best Minds in Longevity Science

NOVOS’ scientific advisors are biochemists, geneticists and professors from Harvard, MIT, University of Liverpool, University of Washington, and other universities around the world. 

Our scientists have received honors that include Breakthroughs in Gerontology Award, an Alzheimer’s Association New Investigator Award, and an Ellison Medical Foundation New Scholar in Aging Award. 

Each one of them is a pioneer in the longevity field and have been featured by 60 Minutes, TIME magazine, BBC, CNN, Science, Scientific American, Washington Post, New York Times, and countless other publications.

Dr. J Pedro Magalhaes, PhD
Harvard Medical School, University of Liverpool

Dr. Magalhaes leads the Integrative Genomics of Aging Group at the Institute of Integrative Biology, University of Liverpool, UK. Dr. Magalhaes completed his postdoc with genomics pioneer, Dr. George Church, at Harvard Medical School. He developed high-throughput approaches for studying aging, including computational tools and databases, statistical models of mortality, and comparative genomics methods for investigating the evolution of longevity. Dr. Magalhaes maintains several databases related to the impact that drugs & natural substances have on aging.

Dr. Pamela Maher, PhD
University of British Columbia, Salk Institute for Biological Studies

Dr. Maher worked for 5 years as an assistant professor at the Whittier Institute for Diabetes and Endocrinology in La Jolla, CA, then moved to The Scripps Research Institute in 1994 as an associate professor. In 2004, she moved to her current position at The Salk Institute. Her research interests focus on using natural products such as flavonoids, small molecules that are widely distributed in fruits and vegetables, to maintain nerve cell function in the presence of toxic insults, especially in relation to Alzheimer’s, dementia & Parkinson’s.

Dr. Oliver Medvedik, PhD
Harvard Medical School, The Cooper Union

Director of the Kanbar Center for Biomedical Engineering, Cooper Union. Dr. Medvedik has worked as a biotechnology consultant at Sirtris Pharmaceuticals and has taught molecular and synthetic biology to hundreds of students while at Harvard University, The Cooper Union, School of Visual Arts, Genspace and NYU. He is also co-founder and vice-president of the non-profit organization LEAF (Life Extension Advocacy Foundation), where he serves on the board of directors. LEAF has launched a crowd-funding platform for fiscally sponsoring research directed towards longevity and diseases of aging.

Dr. Avi Rosenbaum, PhD
Harvard Medical School

Scientist and Consultant, with deep knowledge of the biotech industry. Experience and international network in Genomics, Personalized Medicine, Gene Therapy and Synthetic Biology. Built the first academic Next Generation Sequencing platform. Launched more than ten commercial products. Investor and mentor in biotech, pharma, medical and food-tech companies. Holder of five patents, and co-author of high-profile academic publications with over 2,500 citations.

Dr. Kris Verburgh, MD
University of Antwerp, Singularity University

Expert on the future of Medicine and Biotechnology, Dr. Verburgh is a medical doctor, researcher and author with a profound interest in health, aging and the future of medicine and biotechnology. He researches the impact of the Fourth Industrial Revolution on medicine, health and our bodies. Author of The Longevity Code, lecturer at Singularity University & advisor to the X Prize on aging & longevity.

Dr. Matt Kaeberlein, PhD
Massachusetts Institute of Technology, University of Washington – Consultant

Professor of Pathology, Adjunct Professor of Genome Sciences, and Adjunct Professor of Oral Health Sciences at the University of Washington. Dr. Kaeberlein’s research interests focus on basic mechanisms of aging in order to identify interventions that promote healthspan and improve quality of life. He has published nearly 200 papers in top scientific journals and has been recognized by prestigious awards, including Breakthroughs in Gerontology, Alzheimer’s Association Young Investigator Award, Ellison Medical Foundation New Scholar in Aging, a Murdock Trust Award, Pioneer in Aging, and Vincent Cristofalo Rising Star in Aging Research.


About NOVOS’ nutraceuticals

  • Don’t hide signs of aging, they address the root causes.
  • Are based on real science, not anecdote, tradition or belief.
  • Address many important mechanisms of aging, not just one or two. 
  • Use ingredients found in nature and are safe for long-term use.
  • Our foundational formulation, NOVOS Core, is a water-soluble powder, enabling full doses and absorption of ingredients, not a pill with a small fraction (if NOVOS Core were a pill, it would require 8 capsules!)

Technology to track your progress

We are working on providing you with the best tests to track your health and longevity:

  • Benefit from state-of-the art tests to get a birds-eye view of your health and longevity status. 
  • Test how old you really are (your biological age) instead of relying on your chronological age.
  • Receive guidance on how to improve your biological age with lifestyle tweaks, beyond the NOVOS formula.
  • Keep motivated with regular check-ups and re-testing. 
  • We achieve this using the best-in-class epigenetic tests, hematological tests, and facial tests, based on superior algorithms and AI. 

We fund research to create the best formulations

We’re agnostic to ingredient selection. So we are free to choose the best ingredients proven to improve health span and lifespan. And we fund responsible research in humans, to be confident that our product is the best.


We are a Public Benefit Corporation (PBC)

A portion of our profits and equity is donated to nonprofits in the longevity science space, like the 501(c)(3), Life Extension Advocacy Foundation (LEAF).

We also create free content to educate people on how to live longer, healthier lives, even if they don’t use NOVOS, which you can find here


Our Founders

NOVOS is founded by longevity activists who are in it for the really, really long term!

The team at NOVOS is fascinated by longevity science and in it for the remainder of their very long lives. The team believes that addressing aging is the best way to keep people healthy, avoiding chronic illnesses of age and looking and feeling their best for the longest time possible.

Chris Mirabile
Founder & CEO

Chris Mirabile graduated from NYU’s Stern School of Business in 2006 and later won their business plan competition in 2007 with his startup company, Hotlist, a location-based social network that scaled to 220 million people’s social plans. Chris has since launched multiple successful technology ventures, and has advised biotech startups and NYU Langone Hospital. Chris’s interest in health began when he was 12, and evolved into a passion after he was cured of a brain tumor when he was 16. Chris has researched and integrated longevity practices and interventions into his life for more than ten years.

Dr. Kris Verburgh MD
Founder & CSO

Kris Verburgh graduated magna cum laude as a medical doctor from the University of Antwerp, Belgium. Dr. Verburgh is a researcher at the Center Leo Apostel for Interdisciplinary Studies (CLEA) at the Free University Brussels (VUB) and a member of the Evolution, Complexity and Cognition group at the Free University of Brussels. Dr. Verburgh’s fields of research are aging, nutrition, metabolism, preventive medicine and health. In this context, he created a new scientific discipline, called ‘nutrigerontology’, which studies the impact of nutrition on the aging process and aging-related diseases.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.